跳至主要内容
临床试验/IRCT2014032816490N2
IRCT2014032816490N2已完成3 期

Effects of GnRH and Raloxifen on the size of uterine lyomioma

Vice chancellor for research, Kurdistan University of Medical Sciences0 个研究点目标入组 53 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • not being menopausal, and having a history of lyomiomas with a minimum size of 40 mm and a maximum of 60 mm in one of the diameters of tumor.
  • Exclusion criteria: having metabolic disease, neoplasia disease, infectious diseases, blood disorders; history of venous thrombosis, liver disease, active rheumatoid arthritis; BMI greater than 30 or less than 18 kg/m2; hormone therapy in the last 6 months; surgery in the last 6 months; hypoechoic or calcified lyomiomas; endometrial abnormalities in sonography, and lesions of the cervix.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Kurdistan University of Medical Sciences

相似试验